Implementation of Lecanemab for Alzheimer's Disease Within the Veterans Health Administration: Facilitators and Barriers
Attention to identified facilitators and barriers may be helpful for facilities implementing amyloid targeting therapy for AD.
Authors
- Naveen M. Reddy
- Steven M. Handler (ORCID: https://orcid.org/0000-0002-3940-3224)
- Alison O’Donnell (ORCID: https://orcid.org/0000-0002-1326-676X)
- A. Fortunato
- Shaye A Kerper (ORCID: https://orcid.org/0009-0007-3339-2222)
Institutions
- San Francisco VA Medical Center (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Geriatric Research Education and Clinical Center (US)
- VA Pittsburgh Healthcare System (US)
Publication Details
- Journal
- Journal of the American Geriatrics Society
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1111/jgs.19577
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.39